2025
The Blood-Cerebrospinal Fluid Barrier as a Potential Entry Site for the SARS-CoV-2 Virus
SOLÁR, Peter; Omar ŠERÝ; Tomáš VOJTÍŠEK; Jan KRAJSA; Michal SRNÍK et. al.Základní údaje
Originální název
The Blood-Cerebrospinal Fluid Barrier as a Potential Entry Site for the SARS-CoV-2 Virus
Autoři
SOLÁR, Peter; Omar ŠERÝ; Tomáš VOJTÍŠEK; Jan KRAJSA; Michal SRNÍK; Radka DZIEDZINSKÁ; Petr KRÁLÍK; Markéta KESSLER; Petr DUBOVÝ; Andrea JOUKAL; Vladimír Josef BALCAR a Marek JOUKAL
Vydání
Journal of Medical Virology, Hoboken, Wiley, 2025, 0146-6615
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10607 Virology
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.600 v roce 2024
Organizační jednotka
Lékařská fakulta
UT WoS
001400677300001
EID Scopus
2-s2.0-85215678630
Klíčová slova anglicky
blood-cerebrospinal fluid barrier; choroid plexus; COVID-19; neuroinvasion; SARS-CoV-2
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 28. 1. 2025 14:58, Mgr. Tereza Miškechová
Anotace
V originále
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an RNA virus responsible for coronavirus disease 2019 (COVID-19). While SARS-CoV-2 primarily targets the lungs and airways, it can also infect other organs, including the central nervous system (CNS). The aim of this study was to investigate whether the choroid plexus could serve as a potential entry site for SARS-CoV-2 into the brain. Tissue samples from 24 deceased COVID-19-positive individuals were analyzed. Reverse transcription real-time PCR (RT-qPCR) was performed on selected brain regions, including the choroid plexus, to detect SARS-CoV-2 viral RNA. Additionally, immunofluorescence staining and confocal microscopy were used to detect and localize two characteristic proteins of SARS-CoV-2: the spike protein S1 and the nucleocapsid protein. RT-qPCR analysis confirmed the presence of SARS-CoV-2 viral RNA in the choroid plexus. Immunohistochemical staining revealed viral particles localized in the epithelial cells of the choroid plexus, with the spike protein S1 detected in the late endosomes. Our findings suggest that the blood-cerebrospinal fluid (B-CSF) barrier in the choroid plexus serves as a route of entry for SARS-CoV-2 into the CNS. This study contributes to the understanding of the mechanisms underlying CNS involvement in COVID-19 and highlights the importance of further research to explore potential therapeutic strategies targeting this entry pathway.
Návaznosti
| MUNI/A/1563/2023, interní kód MU |
|